WHO ICTRP trial
Randomized, double-blind, placebo-controlled, multi-center, proof-of-concept…
EUCTR2008-002628-27-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2008-002628-27-GB |
|---|---|
| Public title | Randomized, double-blind, placebo-controlled, multi-center, proof-of-concept study to assess the efficacy of AIN457 in patients with psoriatic arthritis - CAIN457A2206 |
| Scientific title | Randomized, double-blind, placebo-controlled, multi-center, proof-of-concept study to assess the efficacy of AIN457 in patients with psoriatic arthritis - CAIN457A2206 |
| Primary sponsor | Novartis Pharma Services AG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany;United Kingdom;Netherlands |
| Conditions | Psoriatic arthritis (PsA), which belongs to seronegative spondyloarthropathies (SpA). MedDRA version: 9.1 Level: LLT Classification code 10037160 Term: Psoriatic arthritis |
| Interventions | Product Name: AIN457 Product Code: AIN457 Pharmaceutical Form: Powder for solution for infusion Current Sponsor code: AIN457 Other descriptive name: Recombinant human monoclonal antibody to Il-17 of the IgG1-k-class Concentration unit: mg… |
| Registration date | Jul 25, 2008 |
| Target size | 147 |
| Secondary IDs | CAIN457A2206;not available |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: